Breaking through the 25-day moving average on the 25th. On the emerging markets this week, the rise was significant. While the Nikkei Average was +0.34%, the growth market index was +2.65%, and the growth market 250 index was +2.75%, showing a more noticeable rise than the prime market. Although trading volume did not expand much, some leading stocks and bio-related stocks with large market capitalizations were bought, and the 25-day moving average was broken on June 11th. Although the 25-day moving average had become a resistance line to the upside since March 25th, a relaxed rebound continued after this breakout. The growth market index has risen for the first time in six days this year, and the growth market 250 index has achieved its second six-day winning streak this year since February.
The emerging markets next week will hopefully continue to rebound. As materials such as the rise of major stocks are picked up, investors' minds are improving. It is inferred that there are few investors who handle the growth 250 index, but the return to the level of the May high of 665 points will be considered as a resurgence of the index. Although leading stocks with a large market capitalization such as TKP＜3479＞and GNI Group have fallen sharply, they are gradually recovering, and there will be a need for trading volume to fulfill sell orders waiting for a recovery. Wealthnavi＜7342＞, which rose on weekends, has a very high volume of trading in each price range, rising to the 1450 yen level. Attention should be paid to whether the rebound will continue by fulfilling sell orders waiting for a recovery.
Please use your Futubull account to access the feature.
There were two initial public offerings (IPOs). D&M Company＜189A＞, which listed on the 11th, had an initial price of 1,308 yen, which is 30.8% higher than the offering price, but it was pressed down by selling towards the weekend. In addition, Chordia Therapeutics＜190A＞, which listed on the 14th, had an initial price of 255 yen, which is 66.7% higher than the offering price, but it was mainly sold off at the end of the day.
We hope the rebound will continue, there are six IPOs.
The emerging markets next week will hopefully continue to rebound. As materials such as the rise of major stocks are picked up, investors' minds are improving. It is inferred that there are few investors who handle the growth 250 index, but the return to the level of the May high of 665 points will be considered as a resurgence of the index. Although leading stocks with a large market capitalization such as TKP＜3479＞and GNI Group have fallen sharply, they are gradually recovering, and there will be a need for trading volume to fulfill sell orders waiting for a recovery. Wealthnavi＜7342＞, which rose on weekends, has a very high volume of trading in each price range, rising to the 1450 yen level. Attention should be paid to whether the rebound will continue by fulfilling sell orders waiting for a recovery.
In the next week's IPO, there will be six companies. On the 18th, Intrigroup＜192A＞, an M&A intermediary business, will list. On the 19th, Rice Curry＜195A＞will list, which handles the marketing support of companies using their own SNS data analysis tool. On the 20th, WOLVES HAND＜194A＞, which operates animal hospitals, Townsend＜197A＞, which provides diagnostic pharmaceuticals for external use, and MFS＜196A＞, which handles online home loan services, will list on the prime market. Only Towns will list on the standard market, and the remaining five companies will list on the emerging markets.
Since there are many IPOs in the emerging markets next week, there may be a strong atmosphere of daily stock picking, and it may be difficult for funds to go into leading stocks. Although the winning streak record of the index may be interrupted, if it can be confirmed that the index is firmly above the 25-day moving average and has a stable trend, the improvement of the emerging market mood is expected to be stronger.